The intersection of peptide therapy and gastroenterology is producing some of the most exciting clinical data of 2026. At the forefront of this research is KPV (Lysine-Proline-Valine), a naturally occurring tripeptide that is demonstrating profound capabilities in managing systemic inflammation and repairing the intestinal barrier. As research shifts away from broad immunosuppressants toward targeted, endogenous […]
